Adaptive Biotechnologies | 4:持股變動聲明-高管 PISKEL KYLE
Adaptive Biotechnologies | SC 13G:超過5%持股股東披露文件-Rubric Capital Management LP(9.76%),David Rosen(9.76%)
Adaptive Biotechnologies | SC 13G/A:超過5%持股股東披露文件(修正)-Matrix Capital Management Company LP(0.44%),David E. Goel(0.44%)
Adaptive Biotechnologies | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(7.21%)
Adaptive Biotechnologies | SC 13G:超過5%持股股東披露文件-Nikko Asset Management Americas, Inc.(5.24%)
Adaptive Biotechnologies | 10-Q:2024財年三季報
Adaptive Biotechnologies | 8-K:自適應生物技術公佈2024年第三季度財務業績
Adaptive Biotechnologies | SC 13G:超過5%持股股東披露文件-Sumitomo Mitsui Trust Group, Inc. (“SMTG”)(5.24%),Nikko Asset Management Co., Ltd. (“NAM”)(5.24%)
Adaptive Biotechnologies | SC 13G:超過5%持股股東披露文件-The Vanguard Group(7.21%)
Adaptive Biotechnologies | SC 13G/A:超過5%持股股東披露文件(修正)-Millennium Management LLC(6.4%),Millennium Group Management LLC(6.4%)等
Adaptive Biotechnologies | 4:持股變動聲明-高管 BOBULSKY SUSAN
Adaptive Biotechnologies | 4:持股變動聲明-高管 Taylor Stacy L
Adaptive Biotechnologies | 144:擬議出售證券
Adaptive Biotechnologies | 10-Q:2024財年二季報
Adaptive Biotechnologies | 8-K:自適應生物技術公佈2024年第二季度財務業績
Adaptive Biotechnologies | 8-K:重大事件
Adaptive Biotechnologies | SC 13G:超過5%持股股東披露文件-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%)等
Adaptive Biotechnologies | DEFA14A:其他
Adaptive Biotechnologies | 4:持股變動聲明-高管 PISKEL KYLE
Adaptive Biotechnologies | 10-Q:2024財年一季報
暫無數據